Our financials

Our financials

2019 was a year of strong delivery and growth.

Hence, we updated the peak sales guidance for Cimzia® and Vimpat® and we will continue to accelerate our investments into future growth drivers.

Revenue
Revenue (pie chart)
Recurring EBITDA
Recurring EBITDA (bar chart)
R&D/revenue ratio
R&D/revenue ratio (bar chart)
Increased peak sales guidance

Cimzia®
≥ € 2 billion
by 2024

Vimpat®
≥ € 1.5 billion
by 2022 

2019 financial report